Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Nutex Health (NUTX) Leases (2019 - 2025)

Nutex Health's Leases history spans 7 years, with the latest figure at $27.0 million for Q4 2025.

  • For Q4 2025, Leases fell 87.69% year-over-year to $27.0 million; the TTM value through Dec 2025 reached $27.0 million, down 87.69%, while the annual FY2025 figure was $27.0 million, 87.69% down from the prior year.
  • Leases for Q4 2025 was $27.0 million at Nutex Health, down from $225.7 million in the prior quarter.
  • Across five years, Leases topped out at $247.6 million in Q3 2023 and bottomed at $86989.0 in Q1 2022.
  • The 5-year median for Leases is $64.6 million (2021), against an average of $109.5 million.
  • The largest annual shift saw Leases soared 153498.39% in 2022 before it plummeted 95.38% in 2024.
  • A 5-year view of Leases shows it stood at $64.6 million in 2021, then tumbled by 68.33% to $20.5 million in 2022, then skyrocketed by 760.65% to $176.1 million in 2023, then increased by 24.27% to $218.9 million in 2024, then tumbled by 87.69% to $27.0 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Leases are $27.0 million (Q4 2025), $225.7 million (Q3 2025), and $215.4 million (Q2 2025).